• OPEN AN ACCOUNT
Indian Indices
Sensex
82,532.19 427.40
( 0.52%)
Global Indices
Nasdaq
51,667.44 -701.11
(-1.34%)
Dow Jones
7,446.91 -135.76
(-1.79%)
Hang Seng
58,984.34 -677.68
(-1.14%)
Nikkei 225
10,703.23 -178.32
(-1.64%)
Forex
USD-INR
94.26 0.34
(0.36%)
EUR-INR
103.88 -0.12
(-0.12%)
GBP-INR
124.50 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.38%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
432.1356994
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
39.43
112619.6
EPS(TTM)
Face Value()
Div & Yield %
35.35
2
0.93
 

restaurant br&s asia ltd
IFL Enterprises reports consolidated net loss of Rs 9.25 crore in the March 2026 quarter
May 28,2026
Net loss of IFL Enterprises reported to Rs 9.25 crore in the quarter ended March 2026 as against net profit of Rs 3.04 crore during the previous quarter ended March 2025. Sales declined 59.56% to Rs 29.17 crore in the quarter ended March 2026 as against Rs 72.13 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 3.68 crore in the year ended March 2026 as against net profit of Rs 2.99 crore during the previous year ended March 2025. Sales declined 41.05% to Rs 71.10 crore in the year ended March 2026 as against Rs 120.61 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales29.1772.13 -60 71.10120.61 -41
OPM %-38.362.44 --7.881.58 -
PBDT-11.194.05 PL -3.374.51 PL
PBT-11.193.92 PL -3.684.01 PL
NP-9.253.04 PL -3.682.99 PL